Showing 9751-9760 of 20328 results for "".
- OHSU-led federally funded initiative to evaluate state-regulated psilocybin serviceshttps://reachmd.com/news/ohsu-led-federally-funded-initiative-to-evaluate-state-regulated-psilocybin-services/2485687/A NIDA-funded implementation research initiative led by Oregon Health & Science University (OHSU)
- Commentary: Is the IMQ Mouse Model Hindering Psoriasis Research?https://reachmd.com/news/commentary-is-the-imq-mouse-model-hindering-psoriasis-research/2485698/A perspective piece in the Journal of Investigative Dermatology takes a criticial look at the imiquimod (IMQ) mouse model, suggesting its unversality and commonality may be impeding translational progress in psoriasis resea
- Addiction consults and MOUD initiation in injection-related endogenous endophthalmitishttps://reachmd.com/news/addiction-consults-and-moud-initiation-in-injection-related-endogenous-endophthalmitis/2485690/Hospitalized patients with injection-drug-use–associated endogenous endophthalmitis were described in a Mass General Brigham report
- BMI and Six‑Month Outcomes After Burn Injuryhttps://reachmd.com/news/bmi-burn-injury-outcomes/2485679/BMI category was associated with different 180-day outcomes after adult burn injury in a propensity-matched, real-world analysis. Underweight status was linked to higher mortality and higher
- Systematic Review Supports Efficacy of Targeted HA Chin Injection Strategyhttps://reachmd.com/news/systematic-review-supports-efficacy-of-targeted-ha-chin-injection-strategy/2485670/Chin augmentation with hyaluronic acid (HA) fillers has become a cornerstone of lower facial contouring. In a systematic review and meta-analysis published online in Aesthetic Plastic Surgery, the authors evaluated the safety and efficacy of a two-three-point injection technique for chin
- CORAL Trial Results on Nalbuphine ER for IPF-Associated Chronic Coughhttps://reachmd.com/news/coral-trial-nalbuphine-er-ipf-chronic-cough/2485652/In the phase 2b randomized, double-blind, placebo-controlled CORAL trial, investigators evaluated nalbuphine extended release (ER) for idiopathic pulmonary fibrosis (IPF)-a
- New Findings on Tumor‑Informed ctDNA in Locally Advanced Rectal Cancerhttps://reachmd.com/news/ctdna-locally-advanced-rectal-cancer/2485655/In a multicenter retrospective analysis of 220 patients with stage II-III locally advanced rectal cancer, investigators observed that tumor-informative c
- Invasive GAS Resurgence in Persons Experiencing Homelessnesshttps://reachmd.com/news/invasive-gas-resurgence-in-persons-experiencing-homelessness/2485662/In a population-based surveillance analysis from Toronto and Peel Region, invasive group A Streptococcus infections resurged after the COVID-19 pandemic among adults, with sharply different reported burden between persons experiencing homelessness and housed adults in a two-year dataset dra
- Can Injectables and Facelifts Coexist? Early Data Suggest Yeshttps://reachmd.com/news/can-injectables-and-facelifts-coexist-early-data-suggest-yes/2485646/Facelift surgery remains a foundational procedure for facial rejuvenation, but it may not fully correct age-related volume loss, skin quality changes, or dynamic rhytides. As a result, injectables and energy-based devices are frequently incorporated before and after rhytidectomy, despite limited
- Higher Body Mass Index Linked to Worse Intensive Care Outcomes After Severe Traumahttps://reachmd.com/news/higher-body-mass-index-linked-to-worse-intensive-care-outcomes-after-severe-trauma/2485631/New registry-based research suggests that higher body mass index (BMI) is associated with increased organ failure, longer intensive care stays, and higher in-h